This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Clinical Laserthermia Systems Crescita futura

We currently don't have sufficient analyst coverage to forecast growth and revenue for Clinical Laserthermia Systems.

56.9%

Tasso di crescita degli utili

50.0%

Tasso di crescita dell'EPS

Medical Equipment crescita degli utili	27.0%
Tasso di crescita dei ricavi	56.5%
Rendimento futuro del capitale proprio	n/a
Copertura analitica	Low
Ultimo aggiornamento	24 Feb 2023

Nessun aggiornamento

Nessun aggiornamento

Previsioni di crescita degli utili e dei ricavi

OM:CLS UR B - Stime future degli analisti e dati finanziari passati (SEK Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2025	115	-2	N/A	N/A	1
12/31/2024	44	-45	-48	-45	1
12/31/2023	17	-70	-70	-67	1
3/31/2023	6	-78	-71	-68	N/A
12/31/2022	6	-71	-69	-68	N/A
9/30/2022	3	-81	-81	-81	N/A
6/30/2022	2	-63	-66	-66	N/A
3/31/2022	2	-68	-71	-71	N/A
12/31/2021	2	-64	-67	-66	N/A
9/30/2021	1	-60	-63	-63	N/A
6/30/2021	2	-57	-55	-55	N/A
3/31/2021	2	-47	-41	-41	N/A
12/31/2020	1	-58	-56	-55	N/A
9/30/2020	1	-58	-54	-53	N/A
6/30/2020	2	-57	-54	-54	N/A
3/31/2020	6	-54	-52	-52	N/A
12/31/2019	6	-43	-39	-39	N/A
9/30/2019	6	-38	-37	-36	N/A
6/30/2019	5	-37	-35	-34	N/A
3/31/2019	1	-41	-44	-43	N/A
12/31/2018	8	-33	-41	-39	N/A
9/30/2018	10	-28	-33	-31	N/A
6/30/2018	11	-24	-33	-31	N/A
3/31/2018	12	-15	-29	-24	N/A
12/31/2017	8	-21	-29	-24	N/A
9/30/2017	8	-22	-34	-29	N/A
6/30/2017	8	-26	-28	-24	N/A
3/31/2017	6	-27	-24	-23	N/A
12/31/2016	4	-27	N/A	-20	N/A
9/30/2016	1	-27	N/A	-19	N/A
6/30/2016	0	-23	N/A	-22	N/A
3/31/2016	0	-20	N/A	-17	N/A
12/31/2015	N/A	-17	N/A	-19	N/A
9/30/2015	0	-21	N/A	-21	N/A
6/30/2015	0	-20	N/A	-20	N/A
3/31/2015	0	-20	N/A	-19	N/A
12/31/2014	N/A	-18	N/A	-16	N/A
9/30/2014	0	-16	N/A	-18	N/A
6/30/2014	N/A	-16	N/A	-18	N/A
3/31/2014	N/A	-17	N/A	-17	N/A
12/31/2013	N/A	-18	N/A	-18	N/A
9/30/2013	0	-16	N/A	-13	N/A
6/30/2013	N/A	-15	N/A	-12	N/A
3/31/2013	0	-13	N/A	-11	N/A
12/31/2012	N/A	-13	N/A	-12	N/A
9/30/2012	0	-11	N/A	-10	N/A

Guadagni vs tasso di risparmio: CLS UR B is forecast to remain unprofitable over the next 3 years.

Guadagni vs Mercato: CLS UR B is forecast to remain unprofitable over the next 3 years.

Guadagni ad alta crescita: CLS UR B is forecast to remain unprofitable over the next 3 years.

Ricavi vs Mercato: CLS UR B's revenue (56.5% per year) is forecast to grow faster than the Swedish market (5.5% per year).

Ricavi ad alta crescita: CLS UR B's revenue (56.5% per year) is forecast to grow faster than 20% per year.

ROE futuro: Insufficient data to determine if CLS UR B's Return on Equity is forecast to be high in 3 years time